{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:36:50Z","timestamp":1793371010180,"version":"4.5.0"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaad.2026.08.004","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:22:16Z","timestamp":1786033336000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Injection-site pain levels with biologic medications for atopic dermatitis and psoriasis: A real-life study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5115-8762","authenticated-orcid":false,"given":"Kateryna","family":"Karpoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.08.004_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/CCID.S400679","article-title":"Injections site reactions and biologics for psoriasis: a questionnaire-based real-life study","volume":"16","author":"Megna","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.004_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1573397118666220829123713","article-title":"A systematic literature review of injection site pain perception in adult patients treated with citrate-free and citrate-containing biologic agents","volume":"19","author":"Junker","year":"2023","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.jaad.2026.08.004_bib4","series-title":"Nemluvio\u00ae (nemolizumab-ilto) for injection, for subcutaneous use. Initial U.S. Approval: 2024","year":"2024"},{"key":"10.1016\/j.jaad.2026.08.004_bib5","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.2147\/PPA.S170636","article-title":"Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies","volume":"12","author":"Stauffer","year":"2018","journal-title":"Patient Prefer Adherence"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226032652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226032652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:27:05Z","timestamp":1793370425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226032652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":4,"alternative-id":["S0190962226032652"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.004","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injection-site pain levels with biologic medications for atopic dermatitis and psoriasis: A real-life study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}